1. Home
  2. APLS vs KNTK Comparison

APLS vs KNTK Comparison

Compare APLS & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • KNTK
  • Stock Information
  • Founded
  • APLS 2009
  • KNTK 2017
  • Country
  • APLS United States
  • KNTK United States
  • Employees
  • APLS N/A
  • KNTK N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • KNTK Natural Gas Distribution
  • Sector
  • APLS Health Care
  • KNTK Utilities
  • Exchange
  • APLS Nasdaq
  • KNTK Nasdaq
  • Market Cap
  • APLS 3.3B
  • KNTK 3.5B
  • IPO Year
  • APLS 2017
  • KNTK N/A
  • Fundamental
  • Price
  • APLS $24.27
  • KNTK $51.24
  • Analyst Decision
  • APLS Buy
  • KNTK Buy
  • Analyst Count
  • APLS 18
  • KNTK 9
  • Target Price
  • APLS $45.53
  • KNTK $58.33
  • AVG Volume (30 Days)
  • APLS 1.7M
  • KNTK 951.0K
  • Earning Date
  • APLS 05-06-2025
  • KNTK 05-07-2025
  • Dividend Yield
  • APLS N/A
  • KNTK 6.09%
  • EPS Growth
  • APLS N/A
  • KNTK N/A
  • EPS
  • APLS N/A
  • KNTK 1.02
  • Revenue
  • APLS $781,367,000.00
  • KNTK $1,482,929,000.00
  • Revenue This Year
  • APLS $12.95
  • KNTK $39.12
  • Revenue Next Year
  • APLS $21.35
  • KNTK $16.24
  • P/E Ratio
  • APLS N/A
  • KNTK $50.24
  • Revenue Growth
  • APLS 97.02
  • KNTK 18.03
  • 52 Week Low
  • APLS $23.25
  • KNTK $37.65
  • 52 Week High
  • APLS $59.91
  • KNTK $67.60
  • Technical
  • Relative Strength Index (RSI)
  • APLS 40.15
  • KNTK 37.12
  • Support Level
  • APLS $23.25
  • KNTK $52.15
  • Resistance Level
  • APLS $24.88
  • KNTK $54.94
  • Average True Range (ATR)
  • APLS 0.91
  • KNTK 1.49
  • MACD
  • APLS 0.11
  • KNTK 0.16
  • Stochastic Oscillator
  • APLS 38.35
  • KNTK 26.44

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About KNTK Kinetik Holdings Inc.

Kinetik is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. It operates exclusively in Texas, serving the Permian Basin and connecting fields with market hubs and other large pipelines. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines that transport molecules to the Gulf Coast enabling it to obtain exposure to export markets and international demand.

Share on Social Networks: